Low Dose Carbon Monoxide Exposure in Idiopathic Pulmonary Fibrosis Produces a CO Signature Comprised of Oxidative Phosphorylation Genes

Scientific Reports - United Kingdom
doi 10.1038/s41598-019-50585-3
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

Fatal, Incidental, Idiopathic Pulmonary Fibrosis in a Patient Receiving Long‐term Low‐dose Methotrexate for Psoriasis

Clinical and Experimental Dermatology
Dermatology
2019English

Author's Response: Co-Trimoxazole Treatment in Idiopathic Pulmonary Fibrosis

Thorax
PulmonaryRespiratory Medicine
2013English

Idiopathic Pulmonary Fibrosis

Pulmonologiya
PulmonaryRespiratory Medicine
2015English

Idiopathic Pulmonary Fibrosis

2020English

Epigenomics of Idiopathic Pulmonary Fibrosis

American Journal of Respiratory and Critical Care Medicine
PulmonaryCritical CareRespiratory MedicineIntensive Care Medicine
2012English

Managing Comorbidities in Idiopathic Pulmonary Fibrosis

International Journal of General Medicine
Medicine
2015English

Cell Therapy in Idiopathic Pulmonary Fibrosis†

Medical Sciences
2018English

Treating Idiopathic Pulmonary Fibrosis With the Addition of Co-Trimoxazole: A Randomised Controlled Trial

Thorax
PulmonaryRespiratory Medicine
2012English

Serum Biomarkers in Idiopathic Pulmonary Fibrosis

Pulmonary Pharmacology and Therapeutics
BiochemistryMedicinePulmonaryRespiratory MedicinePharmacology
2010English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy